The Japanese journal of surgery

, Volume 17, Issue 2, pp 83–90 | Cite as

Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma

  • Fumio Koba
  • Tsuyoshi Akiyoshi
  • Shinya Arinaga
  • Tetsuya Wada
  • Hideo Tsuji
Original Articles


The cell-mediated cytotoxic activities of cells from the perigastric lymph nodes (LNC) were assayed in patients with gastric carcinoma. These activities were compared with those of the peripheral blood mononuclear cells (PBM), and also with the LNC of patients with benign lesions. The capacity of LNC to be converted to cytotoxic cells in mixed cell culture was significantly impaired in the cancer patients as compared to that of either the PBM from the same patients, or the LNC from patients with benign lesions. The natural killer cell (NK) activity of LNC was significantly lower than that of the PBM in both groups of patients. The cytotoxic activity induced by phytohemagglutinin activation (PAK) in the LNC from patients with carcinoma, as well as from those with benign lesions was also significantly decreased, when compared to that of the PBM, although the ability of LNC to produce interleukin 2 (IL 2) was significantly increased. The ability of these cells to generate cytotoxicity after activation with IL 2 (LAK) was therefore examined, and a decreased capacity in LNC was observed. These results indicated that the ability of T cells in LNC to develop into cytotoxic cells in patients with gastric carcinoma was impaired, and that the nonspecific cytotoxicity, including NK or PAK, as well as LAK activity, was essentially low in the perigastric lymph nodes.

Key Words

cell-mediated cytotoxicity regional lymph nodes gastric carcinoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Niitsuma M, Golub SH, Edelstein R, Holmes EC. Lymphoid cells infiltrating human pulmonary tumors: Effect of intralesional BCG injection. JNCI 1981; 76: 996–1003.Google Scholar
  2. 2.
    Vose BM, Vanky F, Argov S, Klein E. Natural cytotoxicity in man: Activity of lymph node and tumorinfiltrating lymphocytes. Eur J Immunol 1977; 7: 753–757.Google Scholar
  3. 3.
    Moore M, Vose BM. Extravascular natural cytotoxicity in man: Anti-K-562 activity of lymph node and tumor-infiltrating lymphocytes. Int J Cancer 1981; 27: 265–272.PubMedGoogle Scholar
  4. 4.
    Cunningham-Rundles S, Fillippa DA, Braum DW Jr, Antonelli P, Ashikari H. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. JNCI 1981; 67: 585–590.PubMedGoogle Scholar
  5. 5.
    Mazumder A, Grimm EA, Zhang HZ, Rosenberg SA. Lysis of fresh human solid tumors by autologous lymphocytes activatedin vitro with lectins. Cancer Res 1983; 42: 913–918.Google Scholar
  6. 6.
    Mazumder A, Grimm EA, Rosenberg SA. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activatedin vitro with phytohemagglutinin. J Immunol 1983; 130: 958–64.PubMedGoogle Scholar
  7. 7.
    Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823–1841.PubMedCrossRefGoogle Scholar
  8. 8.
    Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med 1983; 157: 884–897.PubMedCrossRefGoogle Scholar
  9. 9.
    Grimm EA, Robb RJ, Ross JA, Neckers LM, Lachman LB, Wilson DJ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. III. Evidence that IL 2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med 1983; 158: 1356–1367.PubMedCrossRefGoogle Scholar
  10. 10.
    Abo T, Balch C. Characterization of HNK-1 (Leu-7+) human lymphocytes. II. Distinguishing phenotype and functional properties of natural killer cells from activated NK-like cells. J Immunol 1982; 129: 1758–1761.PubMedGoogle Scholar
  11. 11.
    Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981; 11: 127–129.CrossRefGoogle Scholar
  12. 12.
    Tilden AB, Balch CM. A comparison of PGE2 effects on human suppressor cell function and on interleukin 2 function. J Immunol 1982; 129: 2469–2473.PubMedGoogle Scholar
  13. 13.
    Spina CA, Dorey F, Vescera C, Brosman S, Fahey JL. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Cancer Res 1981; 4324–4330.Google Scholar
  14. 14.
    Holmes EC. Immunology of tumor infiltrating lymphocytes. Ann Surg 1985; 201: 158–163.PubMedGoogle Scholar
  15. 15.
    Antonelli P, Stewart W II, Dupont B Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes and spleen and the effect ofin vitro treatment with interferon preparation. Clin Immunol Immunopathol 1981; 19: 161–169.PubMedCrossRefGoogle Scholar
  16. 16.
    Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 12: 1024–1029.Google Scholar
  17. 17.
    Gibson PR, Verhaar HJJ, Selby WS, Jewell DP. The mononuclear cells of human mesenteric blood, intestinal mucosa and mesenteric lymph nodes: Compartmentalization of NK cells. Clin Exp Immunol 1984; 56: 445–452.PubMedGoogle Scholar
  18. 18.
    Ritchie AWS, James K, Micklem HS. The distribution and possible significance of cells identified in human lymphoid tissue by monoclonal antibody HNK-1. Clin Exp Immunol 1983; 51: 439–447.PubMedGoogle Scholar
  19. 19.
    Si L, Whiteside TL. Tissue distribution of human NK cells studied with anti-Leu-7 monoclonal antibody. J Immunol 1983; 130: 2149–2155.PubMedGoogle Scholar
  20. 20.
    Rayner AA, Grimm EA, Lotze MT, Wilson DJ, Rosenberg SA. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. JNCI 1985; 75: 67–75.PubMedGoogle Scholar
  21. 21.
    Hogan PG, Hapel AJU, Doe WF. Lymphokineactivated and natural killer cell activity in human intestinal mucosa. J Immunol 1985; 135: 1731–1738.PubMedGoogle Scholar
  22. 22.
    Ruco LP, Stoppacciaro A, Valtieri M, Uccini S, Vitolo D, Baroni CD T-lymphocyte subsets in human lymph nodes: Relative increase of OKT-8+ cells in neoplastic and reactive B-cell proliferation. Clin Immunol Immunopathol 1984; 30: 337–345.PubMedCrossRefGoogle Scholar

Copyright information

© The Japan Surgical Society 1987

Authors and Affiliations

  • Fumio Koba
    • 1
  • Tsuyoshi Akiyoshi
    • 1
  • Shinya Arinaga
    • 1
  • Tetsuya Wada
    • 1
  • Hideo Tsuji
    • 1
  1. 1.Department of Surgery, Medical Institute of BioregulationKyashu UniversityBeppuJapan

Personalised recommendations